Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets. [PDF]
Felsheim BM +11 more
europepmc +1 more source
Prognostic significance of CD8+ T cell Spatial Biomarkers in ER+ and ER- breast cancer: A retrospective cohort study. [PDF]
Walker AE +9 more
europepmc +1 more source
Genomic Characteristics Related to Histology-Based Immune Features in Breast Cancer. [PDF]
Cha YJ +10 more
europepmc +1 more source
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy. [PDF]
Yazdani A +22 more
europepmc +1 more source
HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from the PHERGain Phase II Trial. [PDF]
Llombart-Cussac A +18 more
europepmc +1 more source
A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast Cancer. [PDF]
File DM +10 more
europepmc +1 more source
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer. [PDF]
Prasath V +23 more
europepmc +1 more source
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC). [PDF]
Fernandez-Martinez A +22 more
europepmc +1 more source
Development and Characterization of Syngeneic Orthotopic Transplant Models of Obesity-Responsive Triple-Negative Breast Cancer in C57BL/6J Mice. [PDF]
Carson MS +9 more
europepmc +1 more source

